{"id":320327,"date":"2026-10-21T13:29:41","date_gmt":"2026-10-21T07:59:41","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=320327"},"modified":"2026-10-21T13:29:41","modified_gmt":"2026-10-21T07:59:41","slug":"cardiac-brands-pain-care-portfolio-and-custom-synthesis-stocks-roadmap-milestone-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/cardiac-brands-pain-care-portfolio-and-custom-synthesis-stocks-roadmap-milestone-list\/","title":{"rendered":"3 Cardiac Brands, Pain Care Portfolio and Custom Synthesis Stocks With a Strong Future Roadmap: Torrent Pharmaceuticals, Ipca Laboratories and Divi’s Laboratories"},"content":{"rendered":"

Torrent Pharmaceuticals, Ipca Laboratories and Divi’s Laboratories: ROE of 14.2% to 25.5% and FY22 to FY26 revenue CAGR of 5.1% to 13.6%. Prices as of 20 Oct 2026.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

The three pharma brand and ingredient stocks to watch are Torrent Pharmaceuticals, Ipca Laboratories and Divi’s Laboratories. Their return on equity ranges from 14.2% to 25.5%, and their revenue compound annual growth from FY22 to FY26 ranges from 5.1% to 13.6%. Torrent Pharmaceuticals has the highest return on equity at 25.5%, while Ipca Laboratories has the fastest revenue growth at 13.6% a year. Prices are based on the 20 October 2026 close, and this article is educational, not investment advice.<\/p>\n<\/div>\n

Pharma brand and ingredient stocks cover both ends of the medicine chain, from the products doctors prescribe to the active ingredients that go inside them. Torrent Pharmaceuticals, Ipca Laboratories and Divi’s Laboratories offer a cardiac and central nervous system brand leader, a pain and anti-malarial portfolio with in-house ingredients, and a large custom synthesis supplier.<\/p>\n

This list covers three pharma brand and ingredient stocks with complete current figures: Torrent Pharmaceuticals, Ipca Laboratories and Divi’s Laboratories. Every figure comes from the latest reported financials and the 20 October 2026 market close. Companies without complete current figures were left out.<\/p>\n

Click Here – Get Free Investment Predictions<\/a><\/strong><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n